The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy.

Aubrey, D A

The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy. [electronic resource] - The British journal of surgery Sep 1971 - 648-52 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0007-1323

10.1002/bjs.1800580904 doi


Acid Phosphatase--blood
Aged
Clinical Trials as Topic
Drug Hypersensitivity
Humans
Injections, Intramuscular
Male
Middle Aged
Organ Size
Placebos
Pregnanes--adverse effects
Progestins--adverse effects
Prostate--diagnostic imaging
Prostatic Hyperplasia--drug therapy
Pyuria--complications
Thyroid Gland--drug effects
Urinary Catheterization
Urography